Myocardial uptake of 7′-(Z)-[ 123I]iodorotenone during vasodilator stress in dogs with critical coronary stenoses

Circulation: Cardiovascular Imaging

Volumn 4, Issue 6, 2011, Pages 685-692

  Broisat, Alexis ^a   Ruiz, Mirta ^a   Goodman, Norman C ^a   Hanrahan, Stephen M ^b   Reutter, Bryan W ^b   Brennan, Kathleen M ^b   Janabi, Mustafa ^b   Schaefer, Saul ^c   Watson, Denny D ^a   Beller, George A ^a   VanBrocklin, Henry F ^b,d   Glover, David K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary artery disease; Diagnosis; Myocardial perfusion imaging; Radioisotope

Indexed keywords

7 Z IODOROTENONE I 125; ADENOSINE A2A RECEPTOR; IODINE 125; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MICROSPHERE; THALLIUM 201; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DRUG DISTRIBUTION; DRUG SYNTHESIS; ECHO PLANAR IMAGING; EXPERIMENTAL DOG; HEART HEMODYNAMICS; HEART MUSCLE; HYPEREMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY;

ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; CORONARY CIRCULATION; CORONARY STENOSIS; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; DOGS; ECHOCARDIOGRAPHY, STRESS; HEMODYNAMICS; IMAGE ENHANCEMENT; IODINE RADIOISOTOPES; MALE; RANDOM ALLOCATION; ROTENONE; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 82955173669     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.110.961763     Document Type: Article

References (41)

1. Beller GA, Bergmann SR. Myocardial perfusion imaging agents: SPECT and PET. J Nucl Cardiol. 2004;11:71-86. (Pubitemid 38219572)
2. Cerqueira MD, Garcia EV, Gropler RJ, Udelson JE. Eighth Nuclear Cardiology Invitational Conference Park City, Utah, 2006. J Nucl Cardiol. 2007;14:e15-e25. (Pubitemid 350082591)
3. Beller GA, Watson DD. A welcomed new myocardial perfusion imaging agent for positron emission tomography. Circulation. 2009;119: 2299-2301.
4. Glover DK, Gropler RJ. Journey to find the ideal PET flow tracer for clinical use: are we there yet? J Nucl Cardiol. 2007;14:765-768. (Pubitemid 350082590)
5. Glover DK, Ruiz M, Bergmann EE, Simanis JP, Smith WH, Watson DD, Beller GA. Myocardial technetium-99m-teboroxime uptake during adenosine- induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow. J Nucl Med. 1995;36:476-483.
6. Glover DK, Ruiz M, Edwards NC, Cunningham M, Simanis JP, Smith WH, Watson DD, Beller GA. Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation. 1995;91:813-820.
7. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D. Subcellular distribution and analysis of technetium- 99m-MIBI in isolated perfused rat hearts. J Nucl Med. 1992;33: 1516-1522.
8. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium- 99mtetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med. 1998;39:266-271. (Pubitemid 28114516)
9. Piwnica-Worms DP, Kronauge JF, LeFurgey A, Backus M, Hockett D, Ingram P, Lieberman M, Holman BL, Jones AG, Davison A. Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy. Magn Reson Imaging. 1994;12:641-652. (Pubitemid 24183127)
10. Piwnica-Worms D, Kronauge JF, Delmon L, Holman BL, Marsh JD, Jones AG. Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J Nucl Med. 1990;31: 464-472. (Pubitemid 20144714)
11. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med. 1990;31:1646-1653. (Pubitemid 20347047)
12. Younes A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-tetrofosmin, II: uptake into isolated adult rat heart mitochondria. J Nucl Cardiol. 1995;2:327-333.
13. Schaper J, Meiser E, Stammler G. Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts. Circ Res. 1985;56:377-391. (Pubitemid 15119514)
14. VanBrocklin HF, Hanrahan SM, Enas JD, Nandanan E, O'Neil JP. Mitochondrial avid radioprobes: preparation and evaluation of 7-(Z)- [125I]iodorotenone and 7-(Z)-[125I]iodorotenol. Nucl Med Biol. 2007; 34:109-116. (Pubitemid 46038152)
15. Marshall RC, Powers-Risius P, Reutter BW, Taylor SE, VanBrocklin HF, Huesman RH, Budinger TF. Kinetic analysis of 125I-iodorotenone as a deposited myocardial flow tracer: comparison with 99mTc-sestamibi. J Nucl Med. 2001;42:272-281. (Pubitemid 32150518)
16. Marshall RC, Powers-Risius P, Reutter BW, O'Neil JP, La Belle M, Huesman RH, VanBrocklin HF. Kinetic analysis of 18FBroisat fluorodihydrorotenone as a deposited myocardial flow tracer: comparison to 201Tl. J Nucl Med. 2004;45:1950-1959. (Pubitemid 47618456)
17. Yalamanchili P, Wexler E, Hayes M, Yu M, Bozek J, Kagan M, Radeke HS, Azure M, Purohit A, Casebier DS, Robinson SP. Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. J Nucl Cardiol. 2007;14:782-788. (Pubitemid 350082573)
18. Purohit A, Benetti R, Hayes M, Guaraldi M, Kagan M, Yalamanchilli P, Su F, Azure M, Mistry M, Yu M, Robinson S, Dischino DD, Casebier D. Quinazoline derivatives as MC-I inhibitors: evaluation of myocardial uptake using positron emission tomography in rat and non-human primate. Bioorg Med Chem Lett. 2007;17:4882-4885. (Pubitemid 47187691)
19. Yu M, Guaraldi MT, Mistry M, Kagan M, McDonald JL, Drew K, Radeke H, Azure M, Purohit A, Casebier DS, Robinson SP. BMS- 747158-02: a novel PET myocardial perfusion imaging agent. J Nucl Cardiol. 2007;14:789-798. (Pubitemid 350082572)
20. Heymann MA, Payne BD, Hoffman JI, Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis. 1977;20:55-79. (Pubitemid 8145634)
21. Hatada K, Ruiz M, Riou LM, Lima RL, Goode AR, Watson DD, Beller GA, Glover DK. Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses. J Nucl Cardiol. 2006;13:779-790. (Pubitemid 44913651)
22. Glover DK, Ruiz M, Takehana K, Petruzella FD, Riou LM, Rieger JM, Macdonald TL, Watson DD, Linden J, Beller GA. Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection. Circulation. 2001;104: 1181-1187. (Pubitemid 32830405)
23. Stabin MG. MIRDOSE: personal computer software for internal dose assessement in nuclear medicine. J Nucl Med. 1996;37:538-546. (Pubitemid 26094290)
24. Gosselin RE, Stibitz GR. Rates of solute absorption from tissue depots: theoretical considerations. Pflugers Archiv. 1970;318:85-98.
25. Lima RS, De Lorenzo A, Pantoja MR, Siqueira A. Incremental prognostic value of myocardial perfusion 99m-technetium-sestamibi SPECT in the elderly. Int J Cardiol. 2004;93:137-143. (Pubitemid 38229580)
26. van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM, van Gilst WH, Crijns HJ. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000;35:19-28. (Pubitemid 30061254)
27. Soman P, Dave DM, Udelson JE, Han H, Ouda HZ, Patel AR, Karas RH, Kuvin JT. Vascular endothelial dysfunction is associated with reversible myocardial perfusion defects in the absence of obstructive coronary artery disease. J Nucl Cardiol. 2006;13:756-760. (Pubitemid 44890810)
28. Lodge MA, Bengel FM. Methodology for quantifying absolute myocardial perfusion with PET and SPECT. Curr Cardiol Rep. 2007;9: 121-128. (Pubitemid 46681113)
29. Haley TJ. A review of the literature of rotenone, 1,2,12,12a-tetrahydro- 8,9-dimethoxy-2-(1-methylethenyl)-1-benzopyrano[3,5- b]furo[2,3- h][1]benzopyran-6(6h)-one. J Environ Pathol Toxicol. 1978;1:315-337. (Pubitemid 10220625)
30. Charalambous A, Tluczek L, Frey KA, Higgins DS Jr, Greenamyre TJ, Kilbourn MR. Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6- 7-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity. Nucl Med Biol. 1995;22: 491-496.
31. Talpade DJ, Greene JG, Higgins DS Jr, Greenamyre JT. In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone. J Neurochem. 2000;75:2611-2621.
32. Higuchi T, Nekolla SG, Huisman MM, Reder S, Poethko T, Yu M, Wester HJ, Casebier DS, Robinson SP, Botnar RM, Schwaiger M. A new 18F-labeled myocardial PET tracer: myocardial uptake after permanent and transient coronary occlusion in rats. J Nucl Med. 2008;49:1715-1722.
33. Sherif HM, Saraste A, Weidl E, Weber AW, Higuchi T, Reder S, Poethko T, Henriksen G, Casebier D, Robinson S, Wester HJ, Nekolla SG, Schwaiger M. Evaluation of a novel (18)F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats. Circ Cardiovasc Imaging. 2009;2:77-84.
34. Nekolla SG, Reder S, Saraste A, Higuchi T, Dzewas G, Preissel A, Huisman M, Poethko T, Schuster T, Yu M, Robinson S, Casebier D, Henke J, Wester HJ, Schwaiger M. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation. 2009;119:2333-2342.
35. Glover DK, Ruiz M, Yang JY, Smith WH, Watson DD, Beller GA. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 201Tl and regional myocardial blood flow. Circulation. 1997;96: 2332-2338.
36. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, Boucher CA, Picard M, Holman BL, Fridrich R, Inglese E, Delaloye B, Bischof-Delaloye A, Camin L, McKusick K. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med. 1989;30:301-311. (Pubitemid 19077319)
37. Higley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV, Graham D, Hinge D, Davidson J, Lahiri A. Technetium-99m-1,2- bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30-38. (Pubitemid 23014224)
38. Sinusas AJ, Shi Q, Saltzberg MT, Vitols P, Jain D, Wackers FJ, Zaret BL. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med. 1994;35:664-671. (Pubitemid 24114567)
39. Ghezzi C, Fagret D, Arvieux CC, Mathieu JP, Bontron R, Pasqualini R, de Leiris J, Comet M. Myocardial kinetics of TcN-NOET: a neutral lipophilic complex tracer of regional myocardial blood flow. J Nucl Med. 1995;36:1069-1077.
40. Riou LM, Unger S, Toufektsian MC, Ruiz M, Watson DD, Beller GA, Glover DK. Effects of increased lipid concentration and hyperemic blood flow on the intrinsic myocardial washout kinetics of (99m)TcN-NOET. J Nucl Med. 2003;44:1092-1098. (Pubitemid 39663386)
41. Calnon DA, Ruiz M, Vanzetto G, Watson DD, Beller GA, Glover DK. Myocardial uptake of (99m)Tc-N-NOET and (201)Tl during dobutamine infusion: comparison with adenosine stress. Circulation. 1999;100: 1653-1659. (Pubitemid 29477276)